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Introduction
Aminoglycosides are used in treating a wide range 
of infections caused by both Gram-negative and Gram- 
positive bacteria. They have been classified by the World 
Health Organization as critically important antimi-
crobial drugs in human medicine (WHO, 2011). They 
bind specifically to the aminoacyl site (A-site) of 16S 
rRNA within the prokaryotic 30S ribosomal subunits 
and interfere with protein synthesis. The most com-
monly encountered resistance mechanism to amino-
glycosides is enzymatic inactivation. Other known 
mechanisms of aminoglycoside resistance include 
defect of cellular permeability, active efflux and rarely, 
nucleotide substitution of the target molecule (Magnet 
and Blanchard, 2005). Since 2003, a new mechanism 
of aminoglycoside resistance has emerged (Galimand 
et al., 2003; Yokoyama et al., 2003) which is mediated 
by a  newly recognized group of 16S rRNA methyl 
transferases (16S-RMTase), with modest similarity to 
those produced by aminoglycoside-producing acti- 
nomycetes. Their presence confers an extraordinarily 
level of resistance to clinically useful aminoglycosi- 
des, such as amikacin, tobramycin and gentamicin (Doi 
and Arakawa, 2007).
Seven types of plasmid-mediated 16S-RMTase 
(armA, rmtA, rmtB, rmtC, rmtD, rmtE, rmtF and npmA) 
have so far been identified (Davis et al., 2010; Doi et al., 
2004; 2007; Doi and Arakawa, 2007; Galimand et al., 
2003; 2012; Wachino et al., 2006; Yokoyama et al., 
2003). Published data concerning this new group of 
enzymes indicate that 16S-RMTase genes have already 
disseminated globally among pathogenic Gram-nega-
tive bacilli, although their overall prevalence appears to 
remain low (Doi and Arakawa, 2007). 
Genes encoding 16S-RMTases are often carried by 
mobile genetic elements like transposons. They are 
frequently associated with other antimicrobial resist-
ance genes such as blaCTX-M, blaDHA, blaNDM-1, blaOXA-10, 
blaTEM-1, blaVIM-1 as well as plasmid-mediated quinolone 
resistance determinants, thus conferring multidrug 
resistance phenotypes. In addition, some pathogenic 
microbes such as Salmonella species have already 
acquired these genes. Therefore, this genetic apparatus 
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A b s t r a c t
Aminoglycosides are used in treating a wide range of infections caused by Gram-positive and Gram-negative bacteria; however, amino-
glycoside resistance is common and occurs by several mechanisms. Among these mechanisms is bacterial rRNA methylation by the 16S 
rRNA methyl transferase (16S-RMTase) enzymes; but data about the spread of this mechanism in Egypt are scarce. Cephalosporins are the 
most commonly used antimicrobial agents in Egypt; therefore, this study was conducted to determine the frequency of 16S-RMTase among 
third generation cephalosporin-resistant clinical isolates in Egypt. One hundred and twenty three cephalosporin resistant Gram-negative 
clinical isolates were screened for aminoglycosides resistance by the Kirby Bauer disk diffusion method and tested for possible production 
of 16S-RMTase. PCR testing and sequencing were used to confirm the presence of 16S-RMTase and the associated antimicrobial resist-
ance determinants, as well as the genetic region surrounding the armA gene. Out of 123 isolates, 66 (53.66%) were resistant to at least one 
aminoglycoside antibiotic. Only one Escherichia coli isolate (E9ECMO) which was totally resistant to all tested aminoglycosides, was 
confirmed to have the armA gene in association with blaTEM-1, blaCTX-M-15, blaCTX-M-14 and aac(6)-Ib genes. The armA gene was found to be 
carried on a large A/C plasmid. Genetic mapping of the armA surrounding region revealed, for the first time, the association of armA 
with aac(6)-Ib on the same transposon. In conclusion, the isolation frequency of 16S-RMTase was low among the tested aminoglycoside-
resistant clinical samples. However, a novel composite transposon has been detected conferring high-level aminoglycosides resistance. 
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may contribute to the rapid worldwide dissemination 
of this resistance mechanism among different patho-
genic microbes (Yamane et al., 2008; Yang et al., 2011; 
Galani et al., 2012; Poirel et al., 2012; Wachinoa and 
Arakawa, 2012).
Egypt has a high population density (15th world) 
and a central location at the crossroad of major trans-
portation routes, thus it is important to monitor the 
status of antibiotic resistance in this country. However, 
little data about the incidence of 16S-RMTase produc-
ing bacteria in Egypt are available. Since cephalospor-
ins are the most commonly used antibiotics in Egypt 
(Hassan et al., 2011), this investigation was conducted 
to determine the isolation frequency of 16S-RMTase 
producers among third-generation cephalosporin-
resistant Gram-negative pathogenic bacteria in Egyp-
tian medical facilities. In addition, this study also deter-
mined the plasmid origin of armA, the replicon type 
of plasmid, and the 16S-RMTase genetic neighborhood. 
Other associated antimicrobial resistance determinants 
have been studied. 
Experimental
Materials and Methods
Bacterial strains. One hundred and twenty three 
isolates, previously characterized as being resistant to 
at least one of the third-generation cephalosporins, were 
included in the study. All isolates were collected between 
2009 and 2010 from outpatients with suspected infec-
tions, in Abu El-Rish Children’s Hospital, Cairo. Isolates 
were identified by API 20E identification system (Kashif 
et al., 2012). Escherichia coli TOP10 was used as a recipi-
ent strain for transformation experiments. 
Antimicrobial susceptibility testing. Antibiotic 
susceptibility to gentamicin (10 μg), tobramycin (10 μg) 
and amikacin (30 μg) was determined by the Kirby-
Bauer disk diffusion method as proposed by Doi and 
Arakawa (2007).
Isolates with 16S-RMTase genes were tested by the 
Kirby-Bauer disc diffusion method for susceptibility to 
other antimicrobials, such as: ciprofloxacin (5 μg), cefox-
itin (30 μg), cefotaxime (30 μg), piperacillin (100 μg), 
piperacillin/tazobactam (100/10 μg), trimethprim/sul-
famethoxazole (1.25/23.75 μg), imipenem (10 μg). The 
results were interpreted following the guidelines of the 
Clinical and Laboratory Standards Institute (2012a).
Characterization of 16S-RMTase genes and the 
associated antimicrobial resistance genes. Genomic 
DNA was extracted from isolates suspected to contain 
16S-RMTase genes by the boiling method. The isolates 
were tested for armA, rmtA, rmtB, rmtC, rmtD and 
npmA genes by PCR amplification, which was per-
formed as previously described (Doi and Arakawa, 2007; 
Fritsche et al., 2008). PCR identification of other resist-
ance genes (blaTEM, blaSHV, blaCTX-M group 1 and group 
9 and quinolone resistance genes: aac(6)-Ib-cr, qepA, 
qnrA, qnrB and qnrS) was also performed as previously 
described (Park et al., 2005; Cattoir et al., 2007; Yamane 
et al., 2008; Dallenne et al., 2010). PCR products were 
purified with GeneJET PCR Purification Kit (Thermo 
Fisher Scientific, Lithuania) and sequenced by ABI 3730 
xl DNA sequencer (Applied Biosystems, Foster City, 
CA). Similarity searches for the nucleotide sequences 
were performed with BLASTN program (http://www.
ncbi.nlm.nih.gov/blast) with default settings. 
Transformation of 16S-RMTase genes. Plasmid 
DNA was extracted with GeneJET Plasmid Miniprep 
Kit (Thermo Scientific, Lithuania) from 16S-RMTase 
positive strain (E9ECMO). Two microliters of plasmid 
extract from E9ECMO was electroporated into 50 μl of 
electrocompetent E. coli TOP10 cells using a Gene Pul-
ser electroporator (Bio-Rad, Hemel Hempstead, UK), 
according to the manufacturer instructions. Trans-
formants were selected on LB agar medium supple-
mented with either 100 µg/ml cefotaxime, or 100 µg/ml 
gentamicin. The Kirby-Bauer disc diffusion method 
was used to determine the antibiogram of the obtained 
transformants. The MICs of cefotaxime, ciprofloxacin, 
gentamicin and amikacin for isolate E9ECMO, the 
obtained transformants and E. coli TOP10 were deter-
mined by broth microdilution method (CLSI, 2012b).
Plasmid analysis. Plasmid DNA was extracted from 
E9ECMO and the obtained transformants, as previ-
ously described. The size of armA carrying plasmid 
was determined by restriction digestion using BsaBI 
(Thermo Scientific, Lithuania). Electrophoresis of the 
extracted and digested plasmid was performed on 0.5% 
agarose gels in 1 × TAE buffer and visualized by stain-
ing with ethidium bromide. Fragment size was deter-
mined by comparison with Gene-Ruler 1 kb DNA lad-
der (Thermo Scientific, Lithuania). Plasmid replicon 
typing was performed using plasmid DNA extracted 
from E9ECMO as well as from the transformants. This 
was done using PCR-based replicon typing as previ-
ously described by Johnson et al. (2007). 
Determination of armA genetic context. Tn1548 
was identified as the genetic platform that mobilizes 
armA between plasmids in most isolates. PCR mapping 
experiments were performed to investigate the genetic 
context of the armA using the method of Granier et al. 
(2011) with slight modifications. Some primer pairs 
used didn’t produce any amplicons (Tn1-F/Tn1-R, 
Tn2-F/Tn2-R, Tn3-F/Tn3-R and Tn5-F/Tn5-R), so 
modification of the used primer pairs combinations 
was done (Tn1-F/Tn2-R, Tn2-F/ Tn3-R and Tn4-F/
Tn5-R). All PCR products were purified with Gene-
JET PCR Purification Kit (Thermo Fisher Scientific, 
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Lithuania) and sequenced using ABI 3730 xl DNA 
sequencer (Applied Biosystems, Foster City, CA). Simi-
larity searches for the nucleotide sequences were per-
formed with the BLASTN program (http://www.ncbi.
nlm.nih.gov) using default settings.
Results and Discussion
As stated above, the aim of this study was to assess 
the spread of 16S-RMTase resistance genes among 
cephalosporin-resistant bacterial isolates. For this pur-
pose, one hundred and twenty three isolates, obtained 
from Abu El-Rish Children Hospital in Cairo and pre-
viously determined as being resistant to third-genera-
tion cephalosporins, were screened for aminoglycoside 
resistance by the Kirby Bauer disk diffusion method. 
Detection of 16S-RMTase producing isolates. Pro-
duction of 16S-RMTase was suspected when no or little 
inhibitory zone was observed with any of the amino-
glycoside disks (Doi and Arakawa, 2007). Out of 123 
isolates tested, 66 were resistant to aminoglycosides and 
were thus candidates for production of 16S-RMTase. 
However, only one out of those 66 isolates was con-
firmed to possess armA gene by PCR (Fig. 1A) followed 
by sequencing (GenBank accession number KM357401 
and KM357402). The positive isolate (E9ECMO) was 
identified as E. coli. Higher rates were recorded in 
areas such as Korea (32–45%) and China (90%) (Lee 
et al., 2006; Xia et al., 2011; Yang et al., 2011). On the 
other hand, less than 1% prevalence of armA elements 
was recorded in some countries such as Taiwan (0.7%), 
Belgium (0.11%) and Japan (0.03%) (Yamane et al., 
2007; Bogaerts et al., 2010). The low rate, recorded 
Fig. 1. Agarose gel (1.5%) of PCR products of resistance 
determinants and plasmid incompatibility groups from strain 
E9ECMO.
A) M: 100 bp molecular weight ladder, lane 1: positive amplicon
 of armA (315 bp);
B) M: 100 bp molecular weight ladder, lane 2: positive amplicon
 of blaTEM-1, (800 bp), lane 3: positive amplicon of blaCTX-M group 1
 (688 bp), lane 4: positive amplicon of blaCTX-M group 9 (561 bp),
 lane 5: positive amplicon of aac(6)-Ib (482 bp);
C) M: 100 bp molecular weight ladder, lane 6: positive amplicon
 of incI1 (139 bp), lane 7: positive amplicon of incA/C (465 bp).
A B
C
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in this study, may be because most isolates collected 
in this study were from low socioeconomic children 
(2–16 years old) attending outpatient clinics in a govern-
mental hospital in Cairo. Those Children are usually not 
in close contact with animals where 16S-RMTase were 
detected in several instances and thus can spread by 
horizontal dissemination of plasmids (Xia et al., 2011).
E9ECMO is multidrug resistant. E9ECMO was 
also resistant to ciprofloxacin, cefoxitin, cefotaxime, 
piperacillin, piperacillin/ tazobactam and trime- 
thoprim/sulfamethoxazole. The resistance genes 
blaTEM-1, blaCTX-M group 1 (blaCTX-M-15), blaCTX-M group 9 
(blaCTX-M-14) and aac(6)-Ib were also detected by PCR 
and sequencing in E9ECMO (Fig. 1B). This is the same 
resistance tendency as that reported by Bogaerts et al. 
(2010). Confirmed sequences of the resistance genes 
observed in the present study have been deposited 
in GenBank under accession numbers KM357388, 
KM357389, KM357390, KM357391, KM357403, 
KM357404, KM357405 and KM357406.
Transformation of 16S-RMTase genes. Analysis 
of transformants revealed the presence of two types 
of transformants with two corresponding phenotypes: 
i)  Transformant, T1, was resistant to gentamicin, 
tobramycin, amikacin, ciprofloxacin, cefoxitin, cefo-
taxime, piperacillin, piperacillin/tazobactam and tri-
methoprim/sulfamethoxazole. ii)  Transformant, T2, 
showing only high-level resistance to cefotaxime and 
the tested aminoglycosides (gentamicin, amikacin and 
tobramycin) as shown in Table I. PCR testing con-
firmed the presence of armA, blaTEM-1, blaCTX-M group 1 
and group 9 and aac(6)-Ib in transformant T1 while 
only armA, blaCTX-M group 9 and aac(6)-Ib were present 
in transformant T2. 
Plasmid analysis. Plasmid DNA extracted from 
E9ECMO and each of the obtained transformants, was 
separated using gel electrophoresis. The plasmid profile 
of E9ECMO and transformants T1 showed the same 
number and pattern of plasmids. However, the plasmid 
profile of transformant T2 confirmed the presence of 
only one large plasmid in T2 (Fig. 2). Thus, armA is 
carried on a plasmid pMO2; conferring a multidrug 
resistance phenotype. 
Only one linear fragment was obtained after restric-
tion of pMO2 with BsaBI of approximate size 13500 bp. 
Thus, the size of pMO2 was approximately 13500 bp. 
PCR-based replicon typing of plasmids showed that 
plasmids extracted from both E9ECMO and transfor-
mant T1 belonged to incompatibility groups A/C and 
I1 while pMO2 belonged to incompatibility group A/C 
(Fig. 1C). This indicates that armA, blaCTX-M group 9 and 
aac(6)-Ib are borne on A/C type plasmid which is one 
Amikacin < 256   2 < 256 > 256
Gentamicin > 256   0.5 > 256 > 256
Ciprofloxacin > 256 > 0.25 256 4
Cefotaxime > 256   0.5 > 256 > 256
Table I
Minimum Inhibitory Concentration (MIC) of selected
antimicrobials against E9ECMO, E. coli TOP 10, transformant T1
and transformant T2.
Anti-
microbials
MIC (μg/ml)
E9ECMO E. coli TOP 10 T1 T2
Fig. 2. Agarose gel (0.5%) showing the plasmid 
profile of lane M: 1 kb molecular weight ladder, 
1: transformants T2, 2: transformants T1,
3: Isolate E9ECMO.
M                    1                       2                          3
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of the prevalent plasmid families known of carrying 
armA (Carattoli, 2009). The antimicrobial resistance 
pattern of E9ECMO was consistent with the pheno-
type suggested by Kang et al. (2008) for isolates having 
the armA gene carried on A/C type plasmid. This con-
firmed the presence of linkage between armA to other 
associated antimicrobial resistance genes as well as to 
the specific plasmid backbone.
Genetic context of armA in pMO2. Some primer 
pairs used didn’t produce any amplicons, so modifica-
tion of the used primer pairs combinations was done. 
PCR mapping and sequencing experiments revealed 
variation in the sequences upstream of the armA gene 
in transformant T2 from that of the genetic context of 
armA genes reported in E. coli AY522431 and Citro-
bacter freundii AF550415 (Gołebiewski et al., 2007; 
González-Zorn et al., 2005a). This is the first time to 
record a deletion of ant3’’9 (aminoglycoside resistance 
gene) and qacE∆1 (quaternary ammonium compounds 
resistance gene), which were commonly recorded 
upstream from armA in Tn1548. They were replaced 
by another aminoglycoside resistance gene, aac(6)-Ib, 
and this explains the failure to obtain amplicons from 
some previously used primer pair combinations 
(Galimand et al., 2005; González-Zorn et al., 2005b; 
Johnson et al., 2007; Zhang et al., 2008). This coinicides 
with González-Zorn et al. (2005b) conclusion about the 
spread of armA within a unique transposon composite. 
We reveal, for the first time, the presence of aac-6-lb 
gene together with armA on the same transposon. The 
association of armA together with other aminoglyco-
sides resistance gene (aac-6-lb) accounts for the high 
level aminoglycosides resistance conferred by this 
transposon. This genetic combination is worrisome; 
mutation in aac(6)-lb gene can produce its cr allele 
which confers resistance to floroquinolones limiting 
the available choices for treatment of armA associated 
infections (Park et al., 2006).
In addition, other antimicrobial resistance genes 
were detected on the same transposon. The gene sul1 
was detected upstream from armA and confer resistance 
to sulphonamides. The genes coding for the macrolide 
resistance efflux-pump mefE/mel, and a  macrolide 
phosphotransferase gene, mph, were also identified 
downstream of armA gene (Fig. 3A, B). This asso-
ciation necessitates reinforcing the control measures 
Fig. 3.
A) Genetic structure of transposon 1548 in plasmid pMO2 from strain E9ECMO;
B) Agarose gel (1%) of PCR amplicons obtained from transposon 1548 mapping in plasmid pMO2 from strain E9ECMO. M: 1 kb 
molecular weight ladder; lanes 1 to 8: represent amplicons from the following primer pairs combination: (Tn1-F & Tn2-R, Tn 2-F & 
Tn3-R, Tn4-F & Tn4-R, Tn4-F & Tn5R, Tn6-F & Tn6-R, Tn7-F & Tn7-R, Tn8-F & Tn8-R, Tn9-F & Tn9-R).
A
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in both human and animal environment to avoid the 
spread of this aminoglycosides resistance mechanism 
that could be selected by sulphonamides and macro-
lides consumption. 
To the best of our knowledge this is the first article 
discussing the genetic context of 16S-RMTase genes in 
a clinical isolate from Egypt. A partial sequence Tn1548 
variant observed in the present study has been depos-
ited in GenBank under accession numbers KM357386, 
KM357387, KM357392-KM357400 and KM357407.
In conclusion, a novel mobile genetic element car-
ried on a plasmid has been detected in this study, com-
bining armA and aac-6-lb. The pattern and sequence 
of the genetic context suggests a composite transposon. 
The dissemination of this transposon may lead to pan 
aminoglycosides resistance with an impact on morbid-
ity, mortality, and costs of healthcare in both clinical and 
livestock-breeding environments. Organisms possessing 
16S-RMTase genes are usually more likely to develop 
multidrug resistance, because of associated β-lactamase 
genes. Therefore, despite the low rate of prevalence of 
armA in Abu El-Rish children hosptial, strict surveil-
lance should be implemented to limit its local spread. 
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